We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
NICE is endorsing AstraZeneca’s Forxiga as a treatment for Type 2 diabetes in combination with metformin and a sulfonylurea, marking the agency’s third favorable recommendation for the drug.